Magdalena Maciaszek
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Hepatitis C virus research, Vitamin D Research Studies, Hepatitis B Virus Studies, Immune Response and Inflammation
Most-Cited Works
- → Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data(2020)32 cited
- → Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis(2019)15 cited
- → Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis(2020)14 cited
- → The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients(2019)11 cited
- → Adipocyte Fatty Acid‐Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin(2019)11 cited
- → Galectin-3 as a Novel Multifaceted and Not Only Cardiovascular Biomarker in Patients with Psoriasis with Regard to Systemic Treatment—Preliminary Data(2022)9 cited
- → High CD163 Expression on Classical Monocytes Is Associated with Immune Control of HBV Infection in Noncirrhotic Patients(2020)8 cited
- → High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland(2018)8 cited
- → Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data(2022)7 cited
- → Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients(2019)7 cited